Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

AUROBINDO PHARMA LTDAUROBINDO PHARMA LTD
VS
Johnson & Johnson Innovative MedicineJohnson & Johnson Innovative Medicine
AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD

Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District,, Hyderabad, 500032, IN

Last Update: 13/09/2026

View Profile
Between 750 and 799
https://www.aurobindo.com/
781/1000Fair

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, brand...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:14,862
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine

N/A

Last Update: 12/09/2026

View Profile
807/1000Good

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with co...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:37,729
Subsidiaries:10
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for AUROBINDO PHARMA LTD in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Johnson & Johnson Innovative Medicine in 2026.

Incidents

Incident History - AUROBINDO PHARMA LTD (X = Date, Y = Severity)

AUROBINDO PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Johnson & Johnson Innovative Medicine (X = Date, Y = Severity)

Johnson & Johnson Innovative Medicine cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD

Incidents
No explicit notable incidents reported.
Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine

Incidents
No explicit notable incidents reported.

FAQ

Between AUROBINDO PHARMA LTD company and Johnson & Johnson Innovative Medicine company, which one has the best AI Cybersecurity Score ?
Between AUROBINDO PHARMA LTD company and Johnson & Johnson Innovative Medicine company, which one has experienced more cyber incidents in the past ?
Between AUROBINDO PHARMA LTD company and Johnson & Johnson Innovative Medicine company, which one has experienced more cyber incidents this year ?
Between AUROBINDO PHARMA LTD company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one ransomware attack ?
Between AUROBINDO PHARMA LTD company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one data breach ?
Between AUROBINDO PHARMA LTD company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one targeted cyberattack ?
Between AUROBINDO PHARMA LTD company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one vulnerability ?
Between AUROBINDO PHARMA LTD company and Johnson & Johnson Innovative Medicine company, which one holds the most compliance certifications ?
Between AUROBINDO PHARMA LTD company and Johnson & Johnson Innovative Medicine company, which one holds the fewest compliance certifications ?
Between AUROBINDO PHARMA LTD company and Johnson & Johnson Innovative Medicine company, which one has the most subsidiaries ?
Between AUROBINDO PHARMA LTD company and Johnson & Johnson Innovative Medicine company, which one has the largest number of employees ?
Between AUROBINDO PHARMA LTD and Johnson & Johnson Innovative Medicine, which company holds both SOC 2 Type 1 certifications ?
Between AUROBINDO PHARMA LTD and Johnson & Johnson Innovative Medicine, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - AUROBINDO PHARMA LTD or Johnson & Johnson Innovative Medicine ?
Which company is PCI DSS compliant - AUROBINDO PHARMA LTD or Johnson & Johnson Innovative Medicine ?
Between AUROBINDO PHARMA LTD and Johnson & Johnson Innovative Medicine, which company complies with HIPAA regulations for healthcare data ?
Between AUROBINDO PHARMA LTD and Johnson & Johnson Innovative Medicine, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-91201
SUMMARY

DocsGPT through 0.20.0 posts OAuth connector session tokens to a wildcard target origin in the callback-status endpoint without validating sender origin. Attackers can obtain session tokens and provider account emails by acting as window.opener during OAuth authorization, then use tokens to disconnect victims' cloud storage connectors.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 5.4)
CVSS3
Base Score: 5.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
2.5
EXPLOITABILITY
2.8
CVE-2026-91200
SUMMARY

DevSpace through 6.3.21 fails to reject parent-directory segments in tar entry names from the in-pod sync stream. Attackers operating a malicious container can stream tar entries with traversal sequences to write arbitrary files on the developer workstation, enabling code execution.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-91199
SUMMARY

Refly through 1.1.0 contains a server-side request forgery vulnerability in the POST /v1/misc/scrape endpoint that fetches caller-supplied URLs without validating the scheme, host, or resolved address. Authenticated attackers can make the backend issue requests to loopback, private, and link-local addresses including cloud metadata services to read page titles and descriptions of internal resources.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 5)
CVSS3
Base Score: 5.0
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:N/A:N
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:N/SC:L/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.1
CVE-2026-91198
SUMMARY

GrowthBook through 5.0.1 returns unredacted fact table definitions including raw warehouse SQL in payloads served by unauthenticated public report and experiment endpoints. Attackers with knowledge of a publicly shared report or experiment identifier can read internal data warehouse query text, schema, table names, filter values and datasource identifiers.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 5.3)
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.9
CVE-2026-91197
SUMMARY

Flowable flowable-engine through 8.0.0 contains an XML external entity injection vulnerability in ProcessDiagramLayoutFactory.parseXml() that fails to disable external entity resolution when parsing deployed BPMN resources. Attackers with process deployment privileges can embed DOCTYPE declarations with external entities in BPMN files to read arbitrary local files or trigger requests to internal network endpoints when diagram layout is computed.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.8